Oncologix Tech, Inc.（OCLG）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · OCLG · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2017-08	2016-08	2015-08	2014-08	2013-08
Revenue
Revenue	$2.85M	$4.01M	$4.90M	$3.68M	$0.24M
Cost of Revenue	$2.28M	$2.80M	$3.53M	$3.06M	$0.20M
Gross Profit	$0.57M	$1.22M	$1.37M	$0.61M	$0.05M
Gross Margin %(computed)	20.05%	30.28%	28.01%	16.71%	19.88%
Operating Expenses
R&D Expenses	$0.00M	$0.00M	$0.00M	$0.03M	$0.00M
G&A Expenses	$0.00M	$0.00M	$0.00M	$1.13M	$0.33M
Total Operating Expenses	$1.44M	$1.73M	$1.88M	$1.19M	$0.33M
Operating Income	($0.86M)	($0.51M)	($0.51M)	($0.57M)	($0.29M)
Operating Margin %(computed)	-30.35%	-12.76%	-10.38%	-15.56%	-117.50%
Interest Income	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Interest Expense	$1.25M	$0.70M	$1.61M	$0.81M	$0.19M
Income Before Tax	($2.37M)	($1.85M)	($2.55M)	($1.41M)	($0.65M)
Income Tax Expense	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Net Income	($2.37M)	($1.85M)	($2.55M)	($1.31M)	($0.65M)
Net Margin %(computed)	-83.19%	-46.09%	-52.08%	-35.68%	-267.35%
Per Share & EBITDA
EPS (Basic)	$-0.00	$-0.00	$-0.01	$-0.01	$-0.01
Wtd Avg Shares	736.62M	719.84M	316.44M	102.56M	61.86M
EBITDA	($1.11M)	($1.14M)	($0.92M)	($0.58M)	($0.46M)
EBITDA Margin %(computed)	-38.95%	-28.29%	-18.83%	-15.66%	-189.15%